The concept of a purinergic signaling system, using purine nucleotides and nucleosides as
extracellular messengers, was first proposed over 30 years ago. After a brief introduction …

Focuses on the antitachycardia pacing for ventricular tachycardia. Use of implantable
cardioverter defibrillators on ventricular tachycardia; Pathophysiological basis for sustained …

Paroxysmal atrial fibrillation (PAF) is a cardiac arrhythmia that can eventually lead to heart
failure or stroke if left untreated. Early detection of PAF is therefore crucial to prevent any …

Aims Insufficient data exists regarding predictors of electrical storms (ES) and clinical
outcome in patients treated with an implantable cardioverter defibrillator (ICD). The purpose …

An implantable neural stimulation system includes an implantable medical device having a
neural stimulation cir cuit and at least one implantable lead configured to allow one or more …

Objectives: The purpose of this study was to prospectively examine the role of clinical,
laboratory, echocardiographic, and electrophysiological variables as predictors of …

Sudden cardiac death is often caused by a major heart dysfunction with approximately 80%
of occurrences attributed to ventricular arrhythmias. This paper proposes a novel ventricular …

BACKGROUND: Sudden cardiac death due to arrhythmia in the settings of chronic
myocardial infarction (MI) is an important clinical problem. Arrhythmic risk post-MI continues …

Over the last four decades, implantable cardioverter defibrillators (ICDs) have been widely
deployed to reduce sudden cardiac death (SCD) risk in patients with a history of life …

BACKGROUND: Previous studies in implantable cardioverter-defibrillator (ICD) patients
demonstrated the efficacy and safety of antitachycardia pacing (ATP) for rapid ventricular …